Webinar on demand
Dati clinici e ricerche più recenti sulla tecnologia IOL trifocale
26 giugno 2020
· 42 MIN VISIONE
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/lahood.jpg/_jcr_content/renditions/original.image_file.100.100.14,0,329,315.file/lahood.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/lahood.jpg/_jcr_content/renditions/original.image_file.315.315.14,0,329,315.file/lahood.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/lahood.jpg/_jcr_content/renditions/original.image_file.315.315.14,0,329,315.file/lahood.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/lahood.jpg/_jcr_content/renditions/original.image_file.315.315.14,0,329,315.file/lahood.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/lahood.jpg/_jcr_content/renditions/original.image_file.315.315.14,0,329,315.file/lahood.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/lahood.jpg/_jcr_content/renditions/original.image_file.315.315.14,0,329,315.file/lahood.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/lahood.jpg/_jcr_content/renditions/original.image_file.315.315.14,0,329,315.file/lahood.jpg"})
Autore
Dr. Ben LaHood
Eye Institute, Auckland, Nuova Zelanda
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/gupta.jpg/_jcr_content/renditions/original.image_file.100.100.1,0,343,342.file/gupta.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/gupta.jpg/_jcr_content/renditions/original.image_file.342.342.1,0,343,342.file/gupta.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/gupta.jpg/_jcr_content/renditions/original.image_file.342.342.1,0,343,342.file/gupta.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/gupta.jpg/_jcr_content/renditions/original.image_file.342.342.1,0,343,342.file/gupta.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/gupta.jpg/_jcr_content/renditions/original.image_file.342.342.1,0,343,342.file/gupta.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/gupta.jpg/_jcr_content/renditions/original.image_file.342.342.1,0,343,342.file/gupta.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/gupta.jpg/_jcr_content/renditions/original.image_file.342.342.1,0,343,342.file/gupta.jpg"})
Autore
Dr.ssa Aanchal Gupta
Adelaide Eye & Laser Centre, Adelaide, Australia
RIEPILOGO
Dati clinici e ricerche più recenti sulla tecnologia IOL trifocale
Le IOL multifocali sono progettate specificamente per consentire una buona visione non assistita a diverse distanze, ovvero il risultato finale che ogni paziente desidera ottenere. Tuttavia, oggi sono disponibili diverse opzioni sul mercato: qual è la più adatta ai tuoi pazienti?
La Dr.ssa Aanchal Gupta e il Dr. Ben LaHood forniranno un’analisi approfondita delle caratteristiche ottiche e della prestazione clinica di AT LISA tri rispetto ad AcrySof IQ PanOptix e discuteranno il ruolo dell’angolo kappa nell’impianto di IOL multifocali.